Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Beginners often wonder which card type to choose. This intro compares secured vs unsecured options and provides starter tips.
22,834 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
When a fintech stalwart like Fiserv experiences a pullback, it can ripple through the broader market. This guide expl...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
As 2026 brings potential changes to Medicare, retirees and investors face questions about access to care and costs. T...
Investors are eyeing healthequity (hqy) 2026 earnings as HealthEquity navigates an evolving HSA landscape. This guide...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Taiwan Semiconductor faces a 13% pullback that traders are weighing against its AI demand tailwinds and manufacturing...
When a top actor questions late-night formats, it isn’t just showbiz drama. It’s a cautionary tale about revenue shif...
A new mobile AI for health claims to run entirely on your device, delivering medical insights faster and with far les...
KeyBanc cut McDonald’s price target to $330 following a quarterly beat, citing softer April results and challenging y...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
Former White House adviser Kevin Hassett publicly endorses Fed Chair nominee Kevin Warsh's policy plan, signaling a s...